smartrhd
In development — rheumatic heart disease

The #1 acquired heart killer of youth.

We're making technology to catch it early and save lives.

320K+
deaths each year
>90%
of children in endemic regions never screened
$94
a year of penicillin vs $15k–$50k for a valve

The problem

320,000+ deaths a year — mostly children who were never looked at

RHD is the leading cause of acquired cardiovascular death under 25. Strep in crowded homes scars valves. Catch it early and penicillin is enough. Catch it late and the family needs a surgery they cannot buy.

Unreached

Over 90% of children in Oceania, sub-Saharan Africa, and South Asia are never screened.

No specialists

High-income countries have about one pediatric cardiologist per 50k–100k people. Endemic regions often have fewer than one per 5–10 million. Many have none.

Cheap to halt. Costly to wait.

Benzathine penicillin G is about $94 a year and stops progression. Valve replacement is $15,000–$50,000+ — out of reach for most families.

Families concentrate risk

School screening finds about 1.5%–3% prevalence. Screen the siblings of a confirmed case and it jumps to 8%–15% — a 3–5× multiplier that makes targeted screening far more efficient.

Two tools

Different jobs. Different cost.

A smart stethoscope that can live in every school. Guided ultrasound when you need to see silent, early disease.

Analysing

Pulse

Smart stethoscope

A $20–$30 smart stethoscope you can put in every school. It finds the children with more severe, audible valve disease — the ones who need penicillin or referral now.

  • Cheap enough for every school
  • Flags loud, high-risk murmurs in the field
  • Offline ML on a dedicated chest coupler, not a phone mic

Guide

Guided handheld echo

Echo is the only way to see early RHD — before the valve is ruined. Handheld probes already exist ($2,000–$4,500), but pediatric windows are tiny, hearts beat at 100–140 bpm, and unguided scans still miss about 45% of active disease. Guide exists so a non-expert can get the right view.

  • Sees latent RHD a stethoscope cannot
  • On-device guidance to align the probe and capture Doppler, offline
  • Built so a nurse can run echo, not only a cardiologist
Good image quality
Tilt 5° clockwise →

Contact

Work with us

Pilots, research, or funding — if you work on RHD in high-burden settings, write to us.

Pulse and Guide are investigational. Not approved for clinical use.

We respond to all genuine inquiries, typically within 3–5 working days.